COMMUNIQUÉS West-GlobeNewswire

TOMI Environmental Solutions Receives Gold Safety Award from Highwire

03/04/2024 - 14:30

FREDERICK, Md., April 03, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announced today that the [...]

For World Mental Health Day, Jack.org Calls on Communities Across the Country to Come Together to End the Youth Mental Health Emergency

03/04/2024 - 14:30

Jack.org invites you to Canada’s Ride for Youth Mental Health to support life-changing mental health programs for young people CAPTION: Thousands come together for Jack Ride to support programs equipping youth with [...]

À l’occasion de la Journée mondiale de la santé mentale, Jack.org lance un appel national : mobilisons-nous pour éradiquer l’urgence de la santé mentale chez les jeunes

03/04/2024 - 14:30

Jack.org vous invite à prendre part à la course emblématique du Canada pour la santé mentale des jeunes, un soutien vital à travers des programmes révolutionnaires en santé mentale pour notre jeunesse LÉGENDE : Des [...]

Matinas BioPharma Prices $10 Million Registered Direct Offering

03/04/2024 - 14:30

BEDMINSTER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (“Matinas BioPharma” or the “Company”), a clinical-stage biopharmaceutical company focused on delivering [...]

BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia

03/04/2024 - 14:30

ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer of innovative treatment programs for substance use and related disorders, today announced [...]

Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

03/04/2024 - 14:05

Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial Hypertension BOSTON and ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“ [...]

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

03/04/2024 - 14:05

WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN ), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and [...]

“Cutest Pets on Parliament Hill” Photo Contest: Politics and Pets Collide

03/04/2024 - 14:00

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- In a celebration of the importance of furry companionship amidst the hustle and bustle of Canadian politics, the Canadian Animal Health Institute is thrilled to announce the [...]

Concours photo « Les animaux de compagnie les plus mignons sur la Colline du Parlement » – Le monde politique et nos animaux de compagnie : Le grand débat

03/04/2024 - 14:00

TORONTO, 03 avr. 2024 (GLOBE NEWSWIRE) -- Pour souligner l’importance de la compagnie des animaux à fourrure dans l’effervescence de la politique canadienne, l’Institut canadien de la santé animale est ravi d’annoncer [...]

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

03/04/2024 - 14:00

- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved in the collaboration to date - - CytomX-retains US co-commercialization and [...]

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

03/04/2024 - 14:00

PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant [...]

Healthcare Triangle Breaks New Ground in AI-Powered Patient Data Management with readabl.ai

03/04/2024 - 14:00

PLEASANTON, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), In a pioneering move, a leading health system has partnered with [...]

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

03/04/2024 - 14:00

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical cytogenetic [...]

Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

03/04/2024 - 14:00

FLORHAM PARK, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, [...]

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

03/04/2024 - 14:00

Company’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039 DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company [...]

American Oncology Network Expands to Hawaii, Welcomes New Practice to Network

03/04/2024 - 14:00

Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community. HONOLULU, April 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of [...]

CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

03/04/2024 - 14:00

ZUG, Switzerland and BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]

Dr. Marra Francis Joins Genece Health as Chief Medical Officer

03/04/2024 - 14:00

DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, [...]

FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year

03/04/2024 - 14:00

MISSISSAUGA, Ontario, April 03, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® is the #1 recommended iron supplement brand in Canada, based on a national [...]